大行評級 | 瑞銀:市場憂俄烏戰事幹擾內地汽車業供應鏈或反應過度 首選吉利汽車等股
格隆匯3月4日丨瑞銀髮表報告,指市場關注烏克蘭局勢影響汽車供應鏈,認爲汽車股價因此過度下調,估計事件對汽車企業收入損失有限,認爲近期的調整提供了有吸引力的買入機會。該行首選股是敏實集團(0425.HK)、長城汽車(2333.HK)、福耀玻璃(3606.HK)和吉利汽車(0175.HK)。瑞銀表示,長城在俄羅斯圖拉設有工廠,佔總銷量的3%,吉利通過在白俄羅斯的一家小型工廠錄得2%的銷量,福耀在俄羅斯的收入佔比爲2%-3%。該行指出,從歷史上看,盧布貶值導致吉利和長城汽車虧損,也可能侵蝕當地購買力,但這些資產僅佔公司淨資產的2%-3%,與股價跌幅相比爲小。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.